Skip to content
The Policy VaultThe Policy Vault

Thalomid (thalidomide)Medica

Multiple myeloma

Initial criteria

  • age ≥ 18 years
  • Medication is used in combination with at least two other medications (e.g., bortezomib, dexamethasone, cisplatin, doxorubicin, cyclophosphamide, etoposide, carfilzomib)

Approval duration

1 year